Harvard Bioscience Inc
HBIO· Nasdaq
HBIOHarvard Bioscience Inc
Released Jul 26, 2018, after the close
10-Q filed Aug 2, 2018, 33 days after period end · 0001171843-18-005688
| Metric | Q2 2018 | Q2 2017 | Q2 2016 | Q2 2015 |
|---|---|---|---|---|
| Revenue | $31.52M | $18.96M | $26.14M | $28.80M |
| Net Income | -$1.46M | -$381.00K | -$713.00K | $349.00K |
| EPS Diluted |
Harvard Bioscience Inc · CIK 1123494 · Engraved from SEC EDGAR
| -$0.04 |
| -$0.01 |
| -$0.02 |
| $0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
